For the year ending 2025-12-31, OLMA has $533,430K in assets. $54,871K in debts. $48,301K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 48,301 | |||
| Marketable securities | 457,136 | |||
| Prepaid expenses and other current assets | 10,015 | |||
| Total current assets | 515,452 | |||
| Operating lease right-of-use assets | 1,146 | |||
| Other assets and long-term deposits | 16,832 | |||
| Total assets | 533,430 | |||
| Accounts payable | 9,253 | |||
| Operating lease liabilities, current | 1,124 | |||
| Other current liabilities (note 6) | 41,425 | |||
| Total current liabilities | 51,802 | |||
| Operating lease liabilities, net of current portion | 69 | |||
| Long-term borrowing | 3,000 | |||
| Total liabilities | 54,871 | |||
| Common stock, 0.0001 par value 490,000,000 shares authorized as of december 31, 2025 and 2024 81,376,449 and 74,312,608 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 8 | |||
| Additional paid-in capital | 1,075,487 | |||
| Accumulated other comprehensive income | 621 | |||
| Accumulated deficit | -597,557 | |||
| Total stockholders' equity | 478,559 | |||
| Total liabilities and stockholders' equity | 533,430 | |||
Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA)